Global Hepatorenal Syndrome market size is expected to reach $1.91 Billion by 2030 at 6.9%, rising prevalence of liver diseases driving the growth of the market due to increasing risk of kidney dysfunction
Read MoreGlobal Hepatitis Diagnostic Tests market size is expected to reach $6.6.72 billion by 2030 at 6.6%, segmented as by blood tests, serological tests, polymerase chain reaction (pcr) tests, enzyme-linked immunosorbent assays (elisa)
Read MoreGlobal Hepatitis D market size is expected to reach $0.93 billion by 2030 at 4.1%, rising hepatitis b prevalence fuels growth in the market
Read MoreThe hepatitis C testing market will grow from $1.78 in 2024 to $1.32B in 2025 at 6.1% CAGR, driven by rising disease prevalence and expanding health programs.
Read MoreThe hepatitis C market is projected to reach $153.67 billion by 2030, growing at 15.4% CAGR, driven by direct-acting antivirals, early screening, and expanded access to treatment.
Read MoreGlobal Hepatic Encephalopathy market size is expected to reach $2.38 billion by 2030 at 6%, segmented as by antibiotics, rifaximin, neomycin, metronidazole
Read MoreGlobal Hemorrhoids market size is expected to reach $3.96 Billion by 2030 at 6.2%, rising demand for over-the-counter (otc) products driving the growth of the market due to increasing consumer preference for self-care and convenience
Read MoreGlobal Hemorrhage Control System market size is expected to reach $4.67 billion by 2030 at 6.1%, rising prevalence of trauma cases driving the market growth
Read MoreGlobal Hemophilia market size is expected to reach $23.17 billion by 2030 at 9.3%, segmented as by hemophilia a, severe hemophilia a, moderate hemophilia a, mild hemophilia a
Read MoreGlobal Hemophagocytic Lymphohistiocytosis market size is expected to reach $3.24 billion by 2030 at 5.8%, impact of rising prevalence of autoimmune diseases on the market
Read More
